journal.pmed.0020064.pdf (103.37 kB)
Antifibrinolytic agents in traumatic haemorrhage.
journal contributionposted on 2012-10-24, 09:02 authored by Timothy J. Coats, Beverly Hunt, Ian Roberts, Haleema Shakur
This article is an invitation to doctors around the world to participate in the CRASH-2 trial (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage), a large, multi-centre, randomised controlled trial of a simple and widely practicable treatment for traumatic hemorrhage. The rationale for the trial and contact details for those who would like to take part are given below. [Introduction]
CitationPLOS Medicine, 2005, 2 (3), e64
- VoR (Version of Record)